-
1
-
-
0024245572
-
The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation
-
Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med 1988; 148: 2561-2568.
-
(1988)
Arch Intern Med
, vol.148
, pp. 2561-2568
-
-
Talcott, J.A.1
Finberg, R.2
Mayer, R.J.3
Goldman, L.4
-
2
-
-
0033615008
-
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy
-
DOI 10.1056/NEJM199907293410501
-
Freifeld A, Marchigiani D, Walsh T et al. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999; 341: 305-311. (Pubitemid 29350300)
-
(1999)
New England Journal of Medicine
, vol.341
, Issue.5
, pp. 305-311
-
-
Freifeld, A.1
Marchigiani, D.2
Walsh, T.3
Chanock, S.4
Lewis, L.5
Hiemenz, J.6
Hiemenz, S.7
Hicks, J.E.8
Gill, V.9
Steinberg, S.M.10
Pizzo, P.A.11
-
3
-
-
0030701941
-
A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies
-
International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organisation for Research and Treatment of Cancer (EORTC)
-
Hann I, Viscoli C, Paesmans M et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organisation for Research and Treatment of Cancer (EORTC). Br J Haematol 1997; 99: 580-588.
-
(1997)
Br J Haematol
, vol.99
, pp. 580-588
-
-
Hann, I.1
Viscoli, C.2
Paesmans, M.3
-
4
-
-
0033614926
-
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy
-
for the International Antimicrobial Therapy Cooperative Group of the European Organisation for Research and Treatment of Cancer
-
Kern WV, Cometta A, deBock R et al, for the International Antimicrobial Therapy Cooperative Group of the European Organisation for Research and Treatment of Cancer. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999; 341: 312-318.
-
(1999)
N Engl J Med
, vol.341
, pp. 312-318
-
-
Kern, W.V.1
Cometta, A.2
DeBock, R.3
-
5
-
-
70350060244
-
Low-risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care?
-
Ammann RA, Simon A, De Bont E. Low-risk episodes of fever and neutropenia in pediatric oncology: is outpatient oral antibiotic therapy the new gold standard of care? Pediatr Blood Cancer 2005; 44: 1-4.
-
(2005)
Pediatr Blood Cancer
, vol.44
, pp. 1-4
-
-
Ammann, R.A.1
Simon, A.2
De Bont, E.3
-
6
-
-
0037087226
-
2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer
-
DOI 10.1086/339215
-
Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-751. (Pubitemid 34194843)
-
(2002)
Clinical Infectious Diseases
, vol.34
, Issue.6
, pp. 730-751
-
-
Hughes, W.T.1
Armstrong, D.2
Bodey, G.P.3
Bow, E.J.4
Brown, A.E.5
Calandra, T.6
Feld, R.7
Pizzo, P.A.8
Rolston, K.V.I.9
Shenep, J.L.10
Young, L.S.11
-
7
-
-
0034004453
-
"Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia
-
Klaassen RJ, Goodman TR, Pham B, Doyle JJ. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 2000; 18: 1012-1019.
-
(2000)
J Clin Oncol
, vol.18
, pp. 1012-1019
-
-
Klaassen, R.J.1
Goodman, T.R.2
Pham, B.3
Doyle, J.J.4
-
8
-
-
0037439502
-
Epidemiology and risk factors for gram-positive coccal infections in neutropenia: Toward a more targeted antibiotic strategy
-
Cordonnier C, Buzyn A, Leverger G et al. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 2003; 36: 149-158.
-
(2003)
Clin Infect Dis
, vol.36
, pp. 149-158
-
-
Cordonnier, C.1
Buzyn, A.2
Leverger, G.3
-
9
-
-
0035189156
-
Empiric antibiotic prescribing practice in febrile neutropenia: Compliance with IDSA guidelines
-
Newman J, Thompson C, Hussain Z, Bombassaro AM. Empiric antibiotic prescribing practice in febrile neutropenia: compliance with IDSA guidelines. Can J Hosp Pharm 2001; 54: 255-263. (Pubitemid 33094819)
-
(2001)
Canadian Journal of Hospital Pharmacy
, vol.54
, Issue.4
, pp. 255-263
-
-
Newman, J.1
Thompson, C.2
Hussain, Z.3
Bombassaro, A.M.4
-
10
-
-
0036166325
-
Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer
-
DOI 10.1007/s15010-002-2094-1
-
Lehrnbecher T, Stanescu A, Kuhl J. Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer. Infection 2002; 30: 17-21. (Pubitemid 34146407)
-
(2002)
Infection
, vol.30
, Issue.1
, pp. 17-21
-
-
Lehrnbecher, T.1
Stanescu, A.2
Kuhl, J.3
-
11
-
-
0142062516
-
Antimicrobial therapy of unexplained fever in neutropenic patients
-
Link H, Bohme A, Cornely OA et al. Antimicrobial therapy of unexplained fever in neutropenic patients. Ann Hematol 2003; 82 (Suppl 2): S105-S117.
-
(2003)
Ann Hematol
, vol.82
, Issue.SUPPL. 2
-
-
Link, H.1
Bohme, A.2
Cornely, O.A.3
-
12
-
-
0026553534
-
Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia
-
Heney D, Lewis IJ, Evans SW et al. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 1992; 165: 886-890.
-
(1992)
J Infect Dis
, vol.165
, pp. 886-890
-
-
Heney, D.1
Lewis, I.J.2
Evans, S.W.3
-
13
-
-
0041386234
-
Treatment of febrile neutropenic patients with cancer who require hospitalization
-
Raad II, Escalante C, Hachem RY et al. Treatment of febrile neutropenic patients with cancer who require hospitalization. Cancer 2003; 98: 1039-1047.
-
(2003)
Cancer
, vol.98
, pp. 1039-1047
-
-
Raad, I.I.1
Escalante, C.2
Hachem, R.Y.3
-
14
-
-
0036943053
-
Outcomes and costs of febrile neutropenia: Adventures in the science and art of treatment choices
-
Elting LS, Cantor SB. Outcomes and costs of febrile neutropenia: adventures in the science and art of treatment choices. Support Care Cancer 2002; 10: 189-196.
-
(2002)
Support Care Cancer
, vol.10
, pp. 189-196
-
-
Elting, L.S.1
Cantor, S.B.2
-
15
-
-
0036356636
-
Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital
-
DOI 10.1053/jhin.2001.1101, PII S0195670101911016
-
Jugo J, Crowe MJ, McClurg RB et al. Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital. J Hosp Infect 2002; 50: 48-55. (Pubitemid 37554681)
-
(2002)
Journal of Hospital Infection
, vol.50
, Issue.1
, pp. 48-55
-
-
Jugo, J.1
Kennedy, R.2
Crowe, M.J.3
Lamrock, G.4
McClurg, R.B.5
Rooney, P.J.6
Morris, T.C.M.7
Johnston, P.G.8
-
16
-
-
0028270891
-
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients
-
Viscoli C, Bruzzi P, Castagnola E et al. Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. Eur J Cancer 1994; 30A: 430-437.
-
(1994)
Eur J Cancer
, vol.30 A
, pp. 430-437
-
-
Viscoli, C.1
Bruzzi, P.2
Castagnola, E.3
-
17
-
-
0030873259
-
Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: A prospective study
-
Santolaya ME, Villarroel M, Avendano LF, Cofre J. Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study. Clin Infect Dis 1997; 25: 92-97. (Pubitemid 27293081)
-
(1997)
Clinical Infectious Diseases
, vol.25
, Issue.1
, pp. 92-97
-
-
Santolaya, M.E.1
Villarroel, M.2
Avendano, L.F.3
Cofre, J.4
-
18
-
-
0033731128
-
Clinical and laboratory features predicting a favorable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: A literature review
-
DOI 10.1089/15258160050196687
-
Castagnola E, Paola D, Giacchino R, Viscoli C. Clinical and laboratory features predicting a favourable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: a literature review. J Hematother Stem Cell Res 2000; 9: 645-649. (Pubitemid 30848399)
-
(2000)
Journal of Hematotherapy and Stem Cell Research
, vol.9
, Issue.5
, pp. 645-649
-
-
Castagnola, E.1
Paola, D.2
Giacchino, R.3
Viscoli, C.4
-
19
-
-
0035879136
-
Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever
-
Santolaya ME, Alvarez AM, Becker A et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 2001; 19: 3415-3421. (Pubitemid 32642195)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.14
, pp. 3415-3421
-
-
Santolaya, M.E.1
Alvarez, A.M.2
Becker, A.3
Cofre, J.4
Enriquez, N.5
O'Ryan, M.6
Paya, E.7
Pilorget, J.8
Salgado, C.9
Tordecilla, J.10
Varas, M.11
Villarroel, M.12
Viviani, T.13
Zubieta, M.14
-
20
-
-
0346638603
-
Identifying neutropenic febrile cancer patients at risk for early death
-
Wilbur DW, Rentschler RE, Couperas JJ et al. Identifying neutropenic febrile cancer patients at risk for early death. Infect Med 2000; 17: 347-354.
-
(2000)
Infect Med
, vol.17
, pp. 347-354
-
-
Wilbur, D.W.1
Rentschler, R.E.2
Couperas, J.J.3
-
21
-
-
0141960348
-
Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection
-
DOI 10.1002/mpo.10320
-
Ammann RA, Hirt A, Luthy AR, Aebi C. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol 2003; 41: 436-443. (Pubitemid 37229435)
-
(2003)
Medical and Pediatric Oncology
, vol.41
, Issue.5
, pp. 436-443
-
-
Ammann, R.A.1
Hirt, A.2
Luthy, A.R.3
Aebi, C.4
-
22
-
-
0031749504
-
The evolution of the empirical management of fever and neutropenia in cancer patients
-
Viscoli C. The evolution of the empirical management of fever and neutropenia in cancer patients. J Antimicrob Chemother 1998; 41 (Suppl D): 65-80. (Pubitemid 28284508)
-
(1998)
Journal of Antimicrobial Chemotherapy
, vol.41
, Issue.SUPPL. D
, pp. 65-80
-
-
Viscoli, C.1
-
23
-
-
0030020780
-
The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis
-
DOI 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2- V
-
Lucas KG, Brown AE, Armstrong D et al. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 1996; 77: 791-798. (Pubitemid 26055407)
-
(1996)
Cancer
, vol.77
, Issue.4
, pp. 791-798
-
-
Lucas, K.G.1
Brown, A.E.2
Armstrong, D.3
Chapman, D.4
Heller, G.5
-
24
-
-
0842347666
-
Predicting bacteremia in children with fever and chemotherapy-induced neutropenia
-
DOI 10.1097/01.inf.0000106782.30100.4f
-
Ammann RA, Hirt A, Luthy AR, Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis 2004; 23: 61-67. (Pubitemid 38176764)
-
(2004)
Pediatric Infectious Disease Journal
, vol.23
, Issue.1
, pp. 61-67
-
-
Ammann, R.A.1
Hirt, A.2
Luthy, A.R.3
Aebi, C.4
-
25
-
-
0036328732
-
Treatment of febrile neutropenia: What is new?
-
Viscoli C, Castagnola E. Treatment of febrile neutropenia: what is new? Curr Opin Infect Dis 2002; 15: 377-382.
-
(2002)
Curr Opin Infect Dis
, vol.15
, pp. 377-382
-
-
Viscoli, C.1
Castagnola, E.2
-
26
-
-
0029918663
-
Predicting the risk of bacteremia in children with fever and neutropenia
-
Rackoff WR, Gonin R, Robinson C et al. Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol 1996; 14: 919-924. (Pubitemid 26085537)
-
(1996)
Journal of Clinical Oncology
, vol.14
, Issue.3
, pp. 919-924
-
-
Rackoff, W.R.1
Gonin, R.2
Robinson, C.3
Kreissman, S.G.4
Breitfeld, P.P.5
-
27
-
-
0033771464
-
Unusual presentations of infection in neutropenic patients
-
Bodey GP. Unusual presentations of infection in neutropenic patients. Int J Antimicrob Agents 2000; 16: 93-95.
-
(2000)
Int J Antimicrob Agents
, vol.16
, pp. 93-95
-
-
Bodey, G.P.1
-
28
-
-
0028266346
-
C-reactive protein: A valuable aid for the management of febrile children with cancer and neutropenia
-
Santolaya ME, Cofre J, Beresi V. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia. Clin Infect Dis 1994; 18: 589-595. (Pubitemid 24106912)
-
(1994)
Clinical Infectious Diseases
, vol.18
, Issue.4
, pp. 589-595
-
-
Santolaya, M.E.1
Cofre, J.2
Beresi, V.3
-
29
-
-
0029021519
-
Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever
-
Engervall P, Granstrom M, Andersson B, Bjorkholm M. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever. Eur J Haematol 1995; 54: 226-234.
-
(1995)
Eur J Haematol
, vol.54
, pp. 226-234
-
-
Engervall, P.1
Granstrom, M.2
Andersson, B.3
Bjorkholm, M.4
-
30
-
-
0032813989
-
Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and Mannose-binding protein in febrile children with cancer and neutropenia
-
Lehrnbecher T, Venzon D, de Haas M et al. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis 1999; 29: 414-419. (Pubitemid 29380209)
-
(1999)
Clinical Infectious Diseases
, vol.29
, Issue.2
, pp. 414-419
-
-
Lehrnbecher, Th.1
Venzon, D.2
De Haas, M.3
Chanock, S.J.4
Kuhl, J.5
-
31
-
-
3442898259
-
Measurement of C-reative protein in adults with febrile neutropenia after hematopoietic cell transplantation
-
DOI 10.1038/sj.bmt.1704409
-
Ortega M, Rovira M, Almela M et al. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation. Bone Marrow Transplant 2004; 33: 741-744. (Pubitemid 38499929)
-
(2004)
Bone Marrow Transplantation
, vol.33
, Issue.7
, pp. 741-744
-
-
Ortega, M.1
Rovira, M.2
Almela, M.3
De La Bellacasa, J.P.4
Carreras, E.5
Mensa, J.6
-
32
-
-
0029011297
-
A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia
-
Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis 1995; 21: 114-121.
-
(1995)
Clin Infect Dis
, vol.21
, pp. 114-121
-
-
Manian, F.A.1
-
33
-
-
0035880643
-
Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia
-
Baorto EP, Aquino VM, Mullen CA et al. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer 2001; 92: 909-913.
-
(2001)
Cancer
, vol.92
, pp. 909-913
-
-
Baorto, E.P.1
Aquino, V.M.2
Mullen, C.A.3
-
34
-
-
0036255288
-
Value of electronic data for model validation and refinement: Bacteremia risk in children with fever and neutropenia
-
DOI 10.1097/00043426-200205000-00008
-
Madsen K, Rosenman M, Hui S, Breitfeld PP. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia. J Pediatr Hematol Oncol 2002; 24: 256-262. (Pubitemid 34506611)
-
(2002)
Journal of Pediatric Hematology/Oncology
, vol.24
, Issue.4
, pp. 256-262
-
-
Madsen, K.1
Rosenman, M.2
Hui, S.3
Breitfeld, P.P.4
-
35
-
-
0036156259
-
Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer
-
Alexander SW, Wade KC, Hibberd PL, Parsons SK. Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 2002; 24: 38-42.
-
(2002)
J Pediatr Hematol Oncol
, vol.24
, pp. 38-42
-
-
Alexander, S.W.1
Wade, K.C.2
Hibberd, P.L.3
Parsons, S.K.4
-
36
-
-
0033776091
-
Risk factors assessment in febrile neutropenia
-
Paesmans M. Risk factors assessment in febrile neutropenia. Int J Antimicrob Agents 2000; 16: 107-111.
-
(2000)
Int J Antimicrob Agents
, vol.16
, pp. 107-111
-
-
Paesmans, M.1
|